Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells

WANG Yan  LI Qiong ZHANG San-lin  GUO Zhi-kun *

doi:10.16098/j.issn.0529-1356.2017.06.006

PDF(768 KB)

Acta Anatomica Sinica ›› 2017, Vol. 48 ›› Issue (6) : 669-674. DOI: 10.16098/j.issn.0529-1356.2017.06.006

Cell and Molecules Biology

Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells

WANG Yan¹ LI Qiong¹ZHANG San-lin²GUO Zhi-kun ^1*

Author information +

History +

Abstract

Objective To investigate the effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells (BMSCs). Methods The mouse BMSCs were cultured in vitro. We constructed lentivirus of CD73 overexpression and CD73 RNAi vectors and transfected into the BMSCs. The experimental groups were divided into three groups: CD73 overexpression group (OE group), CD73 RNAi interference group (RNAi group) and control group (CON group). Galactosidase (SA-β-Gal) staining was used to detect the cell senescence. Cell proliferation was measured by MTT assay. Cell cycle was detected by flow cytometry. Ultrastructures were observed by transmission electron microscopy (TEM). The cell growth curve was detected by non-injured cell function analyzer. Results The number of senescent cells in RNAi group was significantly higher than that in CON and OE groups (P<0.05) at 72 hours post-transfection. The proliferation of BMSCs in OE group was significantly higher than CON and RNAi groups at 72 and 96 hours post-transfection (P<0.05). The percentages of G₁phase cells in OE group, RNAi group and CON group were 25.9%, 44.1% and 51.7%, respectively, and that of S phase cells were 48.8%, 30.9% and 26.9%, respectively. The percentage of cells in G₂ phase were 25.2%, 25.0% and 21.4%, respectively. The result of transmission electron microscopy showed that the cell rough endoplasmic reticulum and the ribosomes were increased in the OE group. The cell growth curve showed that the cell proliferation ability in OE group was higher than that in CON group and RNAi group. Conclusion CD73 promotes BMSCs proliferation and inhibits BMSC senescence.

Key words

CD73 / Proliferation / Senescence / Bone marrow mesenchymal stem cell / Ultrastructure / Flow cytometry / Mouse

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Yan LI Qiong ZHANG San-lin GUO Zhi-kun. Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells[J]. Acta Anatomica Sinica. 2017, 48(6): 669-674 https://doi.org/10.16098/j.issn.0529-1356.2017.06.006

References

［1］Rosi F, Carlucci F, Marinello E, et al.Ecto-5’-nucleotidase in B-cell chronic lymphocytic leukemia ［ J］.Biomed Pharmacother, 2002, 56(2):100-104.

［2］Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73［J］. Immunol Rev,1998,161:95-109.

［3］Beavis PA, Stagg J, Darcy PK, et al. CD73: a potent suppressor of antitumor immune responses［J］. Trends Immunol, 2012, 33(5): 231-237.

［4］Li Q, Qi LJ, Guo ZK, et al. CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro［J］. J Mol Histol, 2013, 44(4):411-422.

［5］Bavaresco L, Bernardi A, Braganhol E, et al. The role of ecto-5’-nucleotidase/CD73 in glioma cell line proliferation［J］. Mol Cell Bio Chem, 2008, 319(1-2):61-68.

［6］Allard B, Turcotte M, Stagg J. CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth. J Biomed Biotechnol, 2012, 85156.

［7］Park JS，Kim HY, Kim HW, et al．Increased caveolin-1，a cause for the declined adipogenic potential of senescent human mesenehymal stem cells［J］．Mech Ageing，2005, 126(5)：551-559．

［8］Andrade CM, Lopez PL, Noronha BT, et al. Ecto-5’-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line［J］. Cell Tissue Res, 2011, 344(2):279-286.

［9］Gao ZhW, Wang HP, Lin F, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity［J］. BMC Cancer, 2017, 17:135-136.［10］Zhi X, Wang Y, Yu J, et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer［J］. IUBMB Life, 2012，64(11):911-920.

［11］Bynoe MS, Viret C, Yan A, et al. Adenosine receptor signaling: a key to opening the blood-brain door［J］. Fluids Barriers CNS, 2015, 20(12):1-12.

［12］Colgan SP, Eltzschig HK, Eckle T, et al. Physiological roles for ecto-5’-nucleotidase (CD73)［J］. Purinergic Signal, 2006,2(2):351-360.

［13] Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation［J］. N Engl J Med, 2012, 367(24):2322-2333.

［14］Ohta A. A metabolic immune checkpoint: adenosine in tumor microenvironment［J］. Front Immunol, 2016,109(7):1-11.

［15］B?nner F, Borg N, Jacoby C, et al. Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling［J］. Circ Res, 2013, 113(3):301-312.